Fabrication of chondroitin sulfate-chitosan composite artificial extracellular matrix for stabilization of fibroblast growth factor

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 1, 2006, Pages 1-15

  Mi, Fwu Long ^a   Shyu, Shin Shing ^b   Peng, Chih Kang ^c   Wu, Yu Bey ^c   Sung, Hsing Wen ^d   Wang, Pei Shan ^c   Huang, Chi Chuan ^e  

^a Chinese Naval Academy Kaohsiung   (Taiwan)

^b VANUNG UNIVERSITY   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Artificial extracellular matrix; Basic fibroblast growth factor; Chitosan; Chondroitin sulfate

Indexed keywords

BINDING ENERGY; CELL CULTURE; MATRIX ALGEBRA; PHYSIOLOGICAL MODELS;

BASIC FIBROBLAST GROWTH FACTOR; CHITOSAN; CHONDROITIN SULFATE;

BIOMEDICAL ENGINEERING;

BUFFER; CALCIUM ION; CHITOSAN; CHONDROITIN SULFATE; FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; HEPARIN; IMIDE; N HYDROXYSUCCINIMIDE; N,N (3 DIMETHYLAMINOPROPYL) N' ETHYLCARBOIIMIDE; POLYELECTROLYTE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; COMPLEX FORMATION; COMPOSITE MATERIAL; CROSS LINKING; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HYDROLYSIS; IN VITRO STUDY; PROTEIN BINDING; PROTEIN STABILITY; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; CHONDROITIN SULFATES; CROSS-LINKING REAGENTS; DRUG STABILITY; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, WISTAR; TISSUE ENGINEERING; X-RAY DIFFRACTION;

EID: 30444457878     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30298     Document Type: Article

References (37)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260: 920-926.
2. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation Lancet 1999;354:32-34.
3. Abrahma JA, Mergia J, Whang L, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 1986;233:545-548.
4. Canalis E, Centrella M, McCarthy T. Effects of fibroblast growth factor on bone formation in vitro. J Clin Invest 1988; 81:1572-1577.
5. Andreshak JL, Rabin SI, Patwardhan AG, Wezeman FH. Tibial segmental defect repair: chondrogenesis and biomechanical strength modilated by basic fibroblast growth factor. Anat Record 1997;248:198-204.
6. Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990;95:626-631.
7. Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986;128:475-484.
8. Schreiber AB, Kenney J, Kowalski J, Friesel R, Mehlman T. Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc Natl Acad Sci USA 1985;82:6138-6142.
9. Sommer A, Rifkin DB. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J Cell Physiol 1989;138:215-220.
10. Ishihara M, Sato M, Hattori H, Saito Y, Yura H, Ono, K, Masuoka K, Kikuchi M, Fujikawa K, Kurita A. Heparin-carrying polystyrene (HCPS)-bound collagen substratum to immobilize heparin-binding growth factors and to enhance cellular growth. J Biomed Mater Res 2001;56:536-544.
11. van Wachem PB, Plantinga JA, Wissink MJB, Beernink R, Foot AA, Engbers GHM, Beugeling T, van Aken WG, Feijen J, van Luyn MJA. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: effects of crosslink density, heparin immobilization, and bFGF loading J Biomed Mater Res 2001;55:368-378.
12. Tanihara Masao, Suzuki Y, Yamamoto E, Noguchi A, Mizushima Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 2001;56:216-221.
13. Liu LS, Ng CK, Thompson AY, Poser JW, Spiro RC. Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). J Biomed Mater Res 2002;62:128-135.
14. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 2003;65A:489-497.
15. Ishihara M, Obara K, Ishizuka T, Fujita M, Sato M, Masuoka K, Saito Y, Yura H, Matsui T, Hattori H, Kikuchi M, Kurita A. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res 2003;64A: 551-559.
16. Chinen N, Tanihara M, Nakagawa M, Shinozaki K, Yamamoto E, Mizushima Y, Suzuki Y. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. J Biomed Mater Res 2003;67A:61-68.
17. Kunou M, Koizumi M, Shimizu, K, Kawase M, Hatanaka K. Synthesis of sulfated colominic acids and their interaction with fibroblast growth factrors. Biomacromolecules 2000;1:451-458.
18. Mourao PAS, Rozenfeld S, Laredo J, Dietrich CP. The distribution of chondroitin sulfates in articular and growth cartilages of human bones. Biochim Biophys Acta 1976;428:19-26.
19. Conte A, Volpi N, Palmieri L, Bahous I, Ronca G. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneim-Forschung Drug Res 1995;45:918-925.
20. Muzzarelli RAA. Biochemical significance of exogenous chitins in aminals and patients. Carbohydr Polym 1993;20:7-16.
21. Ueno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, Kadosawa T, Fujinaga T. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 1999;20:1407-1414.
22. Muzzarelli RAA, Mattioli-Belmonte M, Tietz C, Zucchini C, Biagini R, Ferioli G, Brunelli M, Fini M, Giardino R, Ilari P, Biagini G, Castaldini C. Stimulatory effect on bone formation exerted by a modified chitosan, Biomaterials 1994;15:1075-1081.
23. Madihally SJ, Mtthew HWT. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999;20:1133-1142.
24. Courtman DW, Errett BF, Wilson, GJ. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res 2001;55: 576-586.
25. Mi FL, Shyu SS, Wu YB, Lee ST, Schoung JY, Huang RN. Fabrication and characterization of a sponge-like asymmetric chitosan membranes as a wound dressing, Biomaterials 2001; 22:165-173.
26. Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic-delivery. J Biomed Mater Res 2002; 59:438-442.
27. Mi FL, Shyu SS, Lin YM, Wu YB, Peng CK, Tsai YH. Chitin/ PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials 2003; 24:5023-5036.
28. Suh JKF, Matthew HWT. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000;21:2589-2598.
29. Mao J, Zhao K, Yao KD, Shang Q, Yang G, Cao Y. Study of novel chitosan-gelatin artificial skin in vitro. J Biomed Mater Res 2003;64A:301-308.
30. Chung TW, Yang J, Akaike T, Cho KY, Nah JW, Kim SI, Cho CS. Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials 2002;23:2827-2834.
31. 2+-induced gelation in alginates and pectins: the egg-box model revisited. Biomacromolecules 2001;2:1089-1096.
32. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92:2952-2962.
33. Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn CM, Waksman G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 1995;268:432-436.
34. Mizuno K, Yamamura K, Yano K, Osada T, Saeki Satomi, Takimoto N, Sakurai T, Nimura Y. Effect of chitosan film containing basic fibroblast growth factor on wound healing in genetically diabetic mice. J Biomed Mater Res 2003;64A:177-181.
35. Park YJ, Lee SN, Park SN, Shin SY, Chung CP, Lee SJ. Platelet-derived growth factor releasing chitosan sponge for periodontal regeneration. Biomaterials 2000;21:153-159.
36. Obara K, Ishihara M, Ishizuka T, Fujita M, Ozeki Y, Maehara T, Saito Y, Yura H, Matsui T, Hattori H, Kikuchi M, Kurita A. Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials 2003;24:3437-3444.
37. Kim SE, Park JH, Cho YW, Chung H, Jeong SY, Lee EB, Kwon IC. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-β-1: implications for cartilage tissue engineering. J Control Rel 2003;91:365-374.